IV Ketamine Therapy uses low-dose infusions administered intravenously to help reset brain pathways involved in mood regulation. This treatment targets NMDA receptors, promoting new neural growth and restoring emotional balance — often within hours or days, rather than weeks.
Each infusion lasts approximately 40–60 minutes in a calm, private room. Our medical team monitors you throughout the session to ensure safety and comfort. Most patients complete an initial six-infusion series over three weeks, with maintenance sessions as needed.
Spravato® is an FDA-approved esketamine nasal spray for adults with treatment-resistant depression. Unlike traditional medications, Spravato® acts quickly on glutamate receptors, helping restore mood stability.
In a medical setting with appropriate screening and monitoring, ketamine therapy can be safe for many people. We monitor patients throughout treatment.
Many patients begin with an initial series (often six sessions) and then continue with maintenance based on response and clinical guidance.
Some patients notice changes within days; others need multiple treatments. Results vary.
Spravato® is often covered for eligible patients. We can help verify benefits and guide the approval process.
Old Westbury residents who have not improved with standard treatments may qualify. A consultation is required to determine eligibility and safety.
Conditions Treated